Invesco Biotechnology & Genome ETF
PBE
PBE
97 hedge funds and large institutions have $73M invested in Invesco Biotechnology & Genome ETF in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
Holders
97
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.08M | |
| 2 | +$1M | |
| 3 | +$647K | |
| 4 |
CC
Cypress Capital
Franklin,
Tennessee
|
+$282K |
| 5 |
LPL Financial
San Diego,
California
|
+$160K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$344K | |
| 3 | -$204K | |
| 4 |
Citigroup
New York
|
-$145K |
| 5 |
Morgan Stanley
New York
|
-$115K |